Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study

MLA

Ferdinands, Jill M., et al. “Waning of Vaccine Effectiveness against Moderate and Severe Covid-19 among Adults in the US from the VISION Network: Test Negative, Case-Control Study.” BMJ (British Medical Journal), vol. 379, no. 10, Jan. 2022, p. e072141. EBSCOhost, https://doi.org/10.1136/bmj-2022-072141.

APA

Ferdinands, J. M., Rao, S., Dixon, B. E., Mitchell, P. K., DeSilva, M. B., Irving, S. A., Lewis, N., Natarajan, K., Stenehjem, E., Grannis, S. J., Han, J., McEvoy, C., Ong, T. C., Naleway, A. L., Reese, S. E., Embi, P. J., Dascomb, K., Klein, N. P., Griggs, E. P., … Fireman, B. (2022). Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study. BMJ (British Medical Journal), 379(10), e072141. https://doi.org/10.1136/bmj-2022-072141

Chicago

Ferdinands, Jill M, Suchitra Rao, Brian E Dixon, Patrick K Mitchell, Malini B DeSilva, Stephanie A Irving, Ned Lewis, et al. 2022. “Waning of Vaccine Effectiveness against Moderate and Severe Covid-19 among Adults in the US from the VISION Network: Test Negative, Case-Control Study.” BMJ (British Medical Journal) 379 (10): e072141. doi:10.1136/bmj-2022-072141.